AstraZeneca has made a dramatic U-turn on its investments in UK life sciences, announcing it will now proceed with a £300 ...
Financing for UK biotech jumped 17% at the start of the year from the previous quarter, with equity financing passing the £0.5bn mark. New figures from the UK BioIndustry Association (BIA) reveal that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results